biotechnology company

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform,announced the successful identification…

- Proceeds to Support Clinical Development of Lead CNS & Liver Programs; IND for Dravet Syndrome is Anticipated by Mid-2023 - New Capital Will…

Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune…

Namodenoson Headed into Pivotal Phase III Liver Cancer Study Can-Fite BioPharma Ltd, a biotechnology company advancing a pipeline of proprietary…

- Potential to bring in-house cell-based therapies that potentiate checkpoint inhibitors Immunomic Therapeutics, Inc., (“ITI”) a privately held…

Calyxt, Inc. a plant-based synthetic biotechnology company, announced the appointment of Seth Dobrin, Ph.D., to the Company's Scientific Advisory…

-OPUL is an end-to-end, cloud-based payment platform designed to cultivate long-term customer relationships and optimize business operations for…

- DKN-01 plus tislelizumab and chemotherapy demonstrated compelling activity in first-line patients with gastric or gastroesophageal junction cancer…

– Funds progression of lead program, an oral approach to treating phenylketonuria (PKU), into the clinic – – Supports expanded application of…

Novellus, a clinical-stage biotechnology company focused on precision oncology, and Tempus, a leader in artificial intelligence and precision…